Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RECORD-3: Everolimus vs Sunitinib Sequencing in mRCC
NCT00903175Phase 2Completed
- Sponsor
- Novartis
- Start
- Oct 2009
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 19
01
Overview
A Phase 2 trial of everolimus in metastatic renal cell carcinoma (mRCC), sponsored by Novartis. Started Oct 2009; status: completed.
02
Drugs
everolimus
03
Conditions
metastatic renal cell carcinoma (mRCC)
Beyond the preview
Go deeper on NCT00903175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00903175.